Evidence map›Paper›PMID 42151186›Full record

ArticleScientific data2026

A longitudinal whole-body CT dataset with manually annotated tumor lesions.

Sergios Gatidis, Felix Peisen, Andreas Wagner, Pauline Ornela Megne Choudja, Ahmed Othman, Antoine Sanner, Nils Grauhan, Suam Kim, Dirk Graafen, Lukas Müller and 7 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sergios Gatidis *Department of Radiology, Stanford University, Stanford, CA, USA. sgatidis@stanford.edu.
Felix Peisen *Department of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Andreas WagnerDepartment of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Pauline Ornela Megne ChoudjaDepartment of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Ahmed OthmanDepartment of Neuroradiology, University Hospital of Mainz, Mainz, Germany.
Antoine SannerDepartment of Neuroradiology, University Hospital of Mainz, Mainz, Germany.
Nils GrauhanDepartment of Neuroradiology, University Hospital of Mainz, Mainz, Germany.
Suam KimDepartment of Neuroradiology, University Hospital of Mainz, Mainz, Germany.
Dirk GraafenDepartment of Radiology, University Hospital of Mainz, Mainz, Germany.
Lukas MüllerDepartment of Radiology, University Hospital of Mainz, Mainz, Germany.
Tanja LoßauFraunhofer MEVIS, Bremen, Germany.
Jan Hendrik MoltzFraunhofer MEVIS, Bremen, Germany.
Temke KohlbrandtFraunhofer MEVIS, Bremen, Germany.
Alessa HeringRadboud University Medical Center, Nijmegen, The Netherlands.
Christian La FougèreNuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany.
Konstantin NikolaouDepartment of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Thomas KüstnerDepartment of Radiology, University Hospital Tuebingen, Tuebingen, Germany.

Funding

Bundesministerium für Forschung und Technologie 01KD2417ADeutsche Forschungsgemeinschaft 428216905 / SPP 2177
6 · The paper itself

Abstract

We introduce Longitudinal-CT, a publicly available resource of whole-body computed tomography (CT) studies with exhaustive expert manual annotations of tumor lesions across two timepoints. The dataset comprises 600 CT studies from 300 patients diagnosed with metastatic malignant melanoma, each including a baseline and a follow-up examination acquired during systemic therapy at the University Hospital Tübingen, Germany. In total, it contains 7,182 manually segmented tumor lesions - 4,079 at baseline and 3,103 at follow-up - each labeled with anatomical location, volume, and longitudinal correspondence to capture lesion evolution such as persistence, regression, merging, or new appearance. All CT data are provided in anonymized NIfTI format with corresponding segmentation masks and lesion metadata. Longitudinal-CT establishes a standardized foundation for developing and validating artificial intelligence methods for automated lesion detection, segmentation, and temporal tracking in oncology. As a reference, a baseline deep learning segmentation model trained using nnU-Net v2 demonstrates the dataset's potential for advancing research in automated oncologic whole-body CT lesion segmentation.

Indexed as

MelanomaTomography, X-Ray ComputedWhole Body ImagingDeep LearningHumansLongitudinal Studies

Identifiers

PMID42151186
PMCPMC13443671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.